Market Cap (In TWD)
1.95 Billion
Revenue (In TWD)
793.77 Million
Net Income (In TWD)
124.62 Million
Avg. Volume
35.8 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 43.95-77.2
- PE
- -
- EPS
- -
- Beta Value
- 0.602
- ISIN
- TW0001796001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jinde Jin
- Employee Count
- -
- Website
- https://www.geneferm.com
- Ipo Date
- 2016-07-26
- Details
- GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health care products in Taiwan and internationally. The company offers microbial fermentation products, which includes mushrooms, lactic acid bacteria, bacteria, yeast, and algae; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, fruits and vegetables fermented enzyme, as well as probiotics and peptide ingredients. It also provides private label supplements; packaging equipment; microbial fermentation toll manufacturing and consulting services. The company was founded in 1988 and is headquartered in Tainan City, Taiwan.
More Stocks
-
KSIkneat.com, inc.
KSI
-
002156
-
GLOSTERLTDGloster Ltd
GLOSTERLTD
-
SHIP
-
2108
-
HCKT
-
VOSVossloh AG
VOS
-
5273